TIDMIUG

Intelligent Ultrasound Group PLC

04 May 2021

4 May 2021

Intelligent Ultrasound Group plc

("IUG" or the "Company")

UK launch of ScanNav Anatomy: Peripheral Nerve Block

Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound artificial intelligence (AI) software and simulation company, announces that, following CE approval earlier this month, it has successfully registered with the MHRA to market ScanNav Anatomy: Peripheral Nerve Block ("ScanNav PNB") in the UK and will be launching the product into the UK market at the forthcoming RA-UK Annual Scientific Meeting.

Dr David Burckett-St.Laurent and Dr James Bowness will be hosting a virtual demonstration of ScanNav PNB at the Regional Anaesthesia UK (RA-UK) Annual Scientific Meeting on 5(th) May 2021. RA-UK is the UK specialist society for anaesthetists interested in the field of regional anaesthesia.

ScanNav PNB uses the latest AI technology to automatically highlight the live ultrasound image to enhance the accuracy and standardisation of ultrasound image interpretation, by making it easier to identify key anatomical structures. This supports the performance of healthcare professionals who are suitably qualified but who perform ultrasound-guided procedures on a less frequent basis.

ScanNav PNB supports nine high-value peripheral nerve blocks (a form of local anaesthesia) and will be sold as a stand-alone device, with in-built AI software, that can be plugged into existing anaesthesiology ultrasound machines. The device will provide clinicians with continuous feedback by real-time highlighting of their live ultrasound scan. Users can also re-familiarise themselves with blocks that they carry out less frequently by using the system's integrated 3D animations.

Increasingly, ultrasound-guided peripheral nerve blocks are being used as a prudent alternative to general anaesthesia, but not all anaesthetists have the specialist knowledge of ultrasound anatomy to perform them. Through the adoption of ScanNav PNB, it is hoped that hospitals will be able to increase the number of ultrasound-guided nerve blocks that they can perform.

The product is configured to work in conjunction with third party ultrasound machines and will be sold as a touchscreen system on a mobile cart. The Company continues to progress its regulatory filing with the FDA to enable a version of the product to be sold in the US, as well as seeking to licence an integrated version of the product to major ultrasound manufacturers.

Lead clinician and consultant anaesthetist, Dr David Burckett-St.Laurent, said: "We look forward to showcasing ScanNav PNB at RA-UK, Sheffield. Based on RA-UK's Plan A blocks, it is our aim that ScanNav PNB will tip the balance of safety and confidence in the aspiring regional anaesthetist through translating anatomical knowledge to sonoanatomy recognition."

For further information, please contact:

 
Intelligent Ultrasound Group                               www. intelligentultrasound.com 
 plc 
Stuart Gall, CEO                                                 Tel: +44 (0)29 2075 6534 
 Helen Jones, CFO 
 
Walbrook PR              Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com 
Anna Dunphy / Paul McManus                            Mob: +44 (0)7876 741 001 / Mob: +44 
                                                                          (0)7980 541 893

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:

Clinical AI Division

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include:

ScanNav Assist

ScanNav Assist uses machine-learning based algorithms to automatically identify and grade ultrasound images. GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received 510(k) clearance from the FDA for sale in the USA. SonoLyst is the world's first fully integrated AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.

ScanNav Anatomy

ScanNav Anatomy PNB uses machine-learning based algorithms to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting software for a range of medical procedures. ScanNav Anatomy has received CE approval and has also been submitted for FDA regulatory approval. ScanNav Anatomy PNB is therefore not available for sale in the US or any other territory requiring government approval for this type of product.

Simulation Division

Focusses on hi-fidelity ultrasound education and training through simulation. Its main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module and the new AI-based Anatomy PNB training simulator. To date over 1,000 simulators have been sold to over 600 medical institutions around the world.

www.intelligentultrasound.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRASSLFSFEFSEII

(END) Dow Jones Newswires

May 04, 2021 02:00 ET (06:00 GMT)

Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Intelligent Ultrasound Charts.
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Intelligent Ultrasound Charts.